July 11th 2025, 9:00pm
By Sue McCarthy
I was diagnosed with breast cancer, then lung cancer 17 years later — and both ultimately led me to make meaningful, positive changes in my life.
July 11th 2025, 8:00pm
By Troy Anderson
A patient on the Monjuvi trial saw lymph nodes shrink 85%, with stable results a year later, supporting the FDA’s recent approval for follicular lymphoma.
July 11th 2025, 7:00pm
By Ethel Marie Slone
Thirteen years after cervical cancer, I’ve found strength in healing, grief in silence, and hope in sharing the quiet truths of survivorship.
July 11th 2025, 5:00pm
By Karen Cohn
Five years after my lymphoma diagnosis, life looks normal on the outside; however, the fear of recurrence and the reality of cancer never fully fade.
July 11th 2025, 4:18pm
By Ryan Scott
Dr. Alexandra Zaleta discussed actionable steps that individuals can take to advocate for a more person-centered insurance practice approach.
July 11th 2025, 3:00pm
By Spencer Feldman
The FDA granted fast track designation to TRE-515 plus radioligand therapy for treating PSMA-positive metastatic castration-resistant prostate cancer.
July 11th 2025, 1:00pm
By Daniel Jernazian
Survivors can find strength after cancer by focusing on goals, loved ones, and spiritual connection, especially during challenging or uncertain times.
July 10th 2025, 9:00pm
By Patti McGee
I found a lump and was shocked to learn it was breast cancer, but over 22 years I’ve learned healing takes time, asking for help is strength, and hope grows.
July 10th 2025, 8:00pm
By Bob Lane
Bob Lane discusses his experience with prostate cancer, and describes what survivorship and cure means to him as someone living with metastatic disease.
July 10th 2025, 7:05pm
Patients with nonmetastatic prostate cancer treated according to NCCN Guidelines are more likely to die of other natural causes than from their cancer.
July 10th 2025, 5:00pm
By Kim Johnson
After nearly 11 years of living with Hodgkin lymphoma, my sister Kathleen passed away peacefully at 39, leaving me to navigate the sorrow of losing her.
July 10th 2025, 4:03pm
Real-world data suggest that Erleada may offer an advantage over other treatment options for patients with metastatic castration-sensitive prostate cancer.
July 10th 2025, 3:00pm
The U.S. FDA has approved a new test for patients with lung cancer to match the correct individuals with a targeted treatment called Zegfrovy.
July 10th 2025, 1:00pm
By Olalekan O. Oluwole
Olalekan O. Oluwole discusses how CAR T-cell therapy is used to treat high-risk hematologic malignancies like lymphoma and leukemia.
July 9th 2025, 9:00pm
By Dr. Dinesh Raj Neupane
Breast cancer care differs around the world, revealing urgent unmet needs in Nepal, where access, support, and treatment remain out of reach for many.
Shining a Spotlight on Pinups4Cancer
Trodelvy Misses Primary Endpoint in ASCENT-07 Breast Cancer Trial
Shining a Light on Pancreatic Cancer Progress and Support
Barbie, Breast Cancer and the Power of Dolls in Healing